Original Investigation
Stress-Associated Neurobiological Pathway Linking Socioeconomic Disparities to Cardiovascular Disease

https://doi.org/10.1016/j.jacc.2019.04.042Get rights and content
Under an Elsevier user license
open archive

Abstract

Background

Lower socioeconomic status (SES) associates with a higher risk of major adverse cardiac events (MACE) via mechanisms that are not well understood.

Objectives

Because psychosocial stress is more prevalent among those with low SES, this study tested the hypothesis that stress-associated neurobiological pathways involving up-regulated inflammation in part mediate the link between lower SES and MACE.

Methods

A total of 509 individuals, median age 55 years (interquartile range: 45 to 66 years), underwent clinically indicated whole-body 18F-fluorodeoxyglucose positron emission tomography/computed tomography imaging and met pre-defined inclusion criteria, including absence of known cardiovascular disease or active cancer. Baseline hematopoietic tissue activity, arterial inflammation, and in a subset of 289, resting amygdalar metabolism (a measure of stress-associated neural activity) were quantified using validated 18F-fluorodeoxyglucose positron emission tomography/computed tomography methods. SES was captured by neighborhood SES factors (e.g., median household income and crime). MACE within 5 years of imaging was adjudicated.

Results

Over a median 4.0 years, 40 individuals experienced MACE. Baseline income inversely associated with amygdalar activity (standardized β: −0.157 [95% confidence interval (CI): −0.266 to −0.041]; p = 0.007) and arterial inflammation (β: −0.10 [95% CI: −0.18 to −0.14]; p = 0.022). Further, income associated with subsequent MACE (standardized hazard ratio: 0.67 [95% CI: 0.47 to 0.96]; p = 0.029) after multivariable adjustments. Mediation analysis demonstrated that the path of: ↓ neighborhood income to ↑ amygdalar activity to ↑ bone marrow activity to ↑ arterial inflammation to ↑ MACE was significant (β: −0.01 [95% CI: −0.06 to −0.001]; p < 0.05).

Conclusions

Lower SES: 1) associates with higher amygdalar activity; and 2) independently predicts MACE via a serial pathway that includes higher amygdalar activity, bone marrow activity, and arterial inflammation. These findings illuminate a stress-associated neurobiological mechanism by which SES disparities may potentiate adverse health outcomes.

Key Words

cardiovascular disease
neurobiology
positron emission tomography
socioeconomic disparities
stress

Abbreviations and Acronyms

18F-FDG-PET/CT
18F-fluorodeoxyglucose positron emission tomography/computed tomography
AmygA
metabolic activity in the amygdala
CVD
cardiovascular disease
MACE
major adverse cardiac event
SES
socioeconomic status

Cited by (0)

This study was supported by U.S. National Institutes of Health grants R01HL122177 and R01HL137913 (to Dr. Tawakol), R01HL128264 (to Dr. Nahrendorf), R01HL071021 and 1P01HL131478 (to Dr. Fayad), and T32HL076136 and KL2TR002542 (to Dr. Osborne); and by American Heart Association grant 18CDA34110366 (to Dr. Osborne). Dr. Tawakol has received grants from Genentech and Actelion; and has received personal fees from Actelion and Amgen. Dr. Nahrendorf has served on the Scientific Advisory Board of Verseau and IFM Therapeutics. Dr. Wasfy has received consulting fees from Biotronik; and has received a Career Development Award from the American Heart Association. Dr. Ridker has received research grants from Novartis, Kowa, and Pfizer; and has consulting agreements with Corvidia, VCiviBio, Janssen, Merck, and Amgen. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. Philip Greenland, MD, served as Guest Associate Editor for this paper.

Listen to this manuscript's audio summary by Editor-in-Chief Dr. Valentin Fuster on JACC.org.